# SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida

> **NCT04596579** · — · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 1135 (actual)

## Conditions studied

- Coronavirus Infection

## Interventions

- **DIAGNOSTIC_TEST:** SARS-CoV-2 Antibody Analysis
- **DIAGNOSTIC_TEST:** Weck-cel Swab Collection
- **BEHAVIORAL:** Web Based Questionnaire

## Key facts

- **NCT ID:** NCT04596579
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-17
- **Primary completion:** 2021-07-25
- **Final completion:** 2021-07-25
- **Target enrollment:** 1135 (ACTUAL)
- **Last updated:** 2022-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04596579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04596579, "SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04596579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*